SU635872A3 - Способполучени производных 2-оксиимино-1,2,3,4,6,7-гексагидро-11 в н-бензо/а/-хинолизина или их солей - Google Patents
Способполучени производных 2-оксиимино-1,2,3,4,6,7-гексагидро-11 в н-бензо/а/-хинолизина или их солейInfo
- Publication number
- SU635872A3 SU635872A3 SU762349651A SU2349651A SU635872A3 SU 635872 A3 SU635872 A3 SU 635872A3 SU 762349651 A SU762349651 A SU 762349651A SU 2349651 A SU2349651 A SU 2349651A SU 635872 A3 SU635872 A3 SU 635872A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- ethanol
- water
- solution
- diastereoisomer
- mixture
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims description 5
- 238000000034 method Methods 0.000 title claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 105
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 47
- 239000000203 mixture Substances 0.000 claims description 37
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 34
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 239000013078 crystal Substances 0.000 claims description 14
- 239000000047 product Substances 0.000 claims description 10
- 238000001953 recrystallisation Methods 0.000 claims description 9
- 239000012452 mother liquor Substances 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 238000010992 reflux Methods 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- MXBFSAYTTZBUBY-UHFFFAOYSA-N n-chlorohydroxylamine Chemical compound ONCl MXBFSAYTTZBUBY-UHFFFAOYSA-N 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 230000008020 evaporation Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- RIZMRRKBZQXFOY-UHFFFAOYSA-N ethion Chemical compound CCOP(=S)(OCC)SCSP(=S)(OCC)OCC RIZMRRKBZQXFOY-UHFFFAOYSA-N 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims 7
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 claims 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 claims 2
- LTYLUDGDHUEBGX-UHFFFAOYSA-N 1-(cyclohexen-1-yl)ethanone Chemical compound CC(=O)C1=CCCCC1 LTYLUDGDHUEBGX-UHFFFAOYSA-N 0.000 claims 1
- ZZZXZQQRTBBNHT-UHFFFAOYSA-N 1-chloropentan-1-ol Chemical compound CCCCC(O)Cl ZZZXZQQRTBBNHT-UHFFFAOYSA-N 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 claims 1
- 238000004821 distillation Methods 0.000 claims 1
- 238000002474 experimental method Methods 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 235000011121 sodium hydroxide Nutrition 0.000 claims 1
- 239000000243 solution Substances 0.000 description 26
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 9
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 9
- 239000002244 precipitate Substances 0.000 description 8
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 5
- 238000001914 filtration Methods 0.000 description 4
- GDRVFDDBLLKWRI-UHFFFAOYSA-N 4H-quinolizine Chemical compound C1=CC=CN2CC=CC=C21 GDRVFDDBLLKWRI-UHFFFAOYSA-N 0.000 description 3
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 3
- 239000011976 maleic acid Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000009193 crawling Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 150000004800 hydroisoquinoline derivatives Chemical class 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 125000005956 isoquinolyl group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940081330 tena Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU75EE2321A HU173181B (hu) | 1975-04-21 | 1975-04-21 | Sposob poluchenija proizvodnykh 2-gidroksi-imino-1,2,3,4,6,7-geksagidro-11bh-benzo/a/khinolizina |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU635872A3 true SU635872A3 (ru) | 1978-11-30 |
Family
ID=10995605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU762349651A SU635872A3 (ru) | 1975-04-21 | 1976-04-21 | Способполучени производных 2-оксиимино-1,2,3,4,6,7-гексагидро-11 в н-бензо/а/-хинолизина или их солей |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4052403A (en:Method) |
| JP (1) | JPS51128999A (en:Method) |
| AT (1) | AT349022B (en:Method) |
| BG (1) | BG34035A3 (en:Method) |
| CH (1) | CH617933A5 (en:Method) |
| CS (1) | CS188281B2 (en:Method) |
| DD (1) | DD125579A5 (en:Method) |
| DE (1) | DE2617440A1 (en:Method) |
| GB (1) | GB1483036A (en:Method) |
| HU (1) | HU173181B (en:Method) |
| PL (1) | PL99556B1 (en:Method) |
| SU (1) | SU635872A3 (en:Method) |
| YU (1) | YU39962B (en:Method) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3055894A (en) * | 1960-03-09 | 1962-09-25 | Pfizer & Co C | New heterocyclic amides |
| AT315844B (de) * | 1970-02-03 | 1974-06-10 | Chem Fab Promonta Ges Mit Besc | Verfahren zur Herstellung von neuen basisch substituierten 2,3,7,8-Tetrahydro-1H-chino[1,8-ab][1]benzazepinen und von ihren Salzen |
-
1975
- 1975-04-21 HU HU75EE2321A patent/HU173181B/hu not_active IP Right Cessation
-
1976
- 1976-04-13 CH CH466276A patent/CH617933A5/de not_active IP Right Cessation
- 1976-04-13 AT AT269176A patent/AT349022B/de not_active IP Right Cessation
- 1976-04-15 DD DD192401A patent/DD125579A5/xx unknown
- 1976-04-15 CS CS762507A patent/CS188281B2/cs unknown
- 1976-04-19 YU YU980/76A patent/YU39962B/xx unknown
- 1976-04-20 PL PL1976188913A patent/PL99556B1/pl unknown
- 1976-04-20 BG BG032967A patent/BG34035A3/xx unknown
- 1976-04-21 DE DE19762617440 patent/DE2617440A1/de not_active Withdrawn
- 1976-04-21 GB GB16078/76A patent/GB1483036A/en not_active Expired
- 1976-04-21 JP JP51044515A patent/JPS51128999A/ja active Granted
- 1976-04-21 US US05/678,902 patent/US4052403A/en not_active Expired - Lifetime
- 1976-04-21 SU SU762349651A patent/SU635872A3/ru active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS51128999A (en) | 1976-11-10 |
| YU39962B (en) | 1985-06-30 |
| CH617933A5 (en:Method) | 1980-06-30 |
| DD125579A5 (en:Method) | 1977-05-04 |
| AT349022B (de) | 1979-03-12 |
| BG34035A3 (en) | 1983-06-15 |
| US4052403A (en) | 1977-10-04 |
| GB1483036A (en) | 1977-08-17 |
| CS188281B2 (en) | 1979-02-28 |
| PL99556B1 (pl) | 1978-07-31 |
| HU173181B (hu) | 1979-03-28 |
| YU98076A (en) | 1982-06-30 |
| JPS5637991B2 (en:Method) | 1981-09-03 |
| ATA269176A (de) | 1978-08-15 |
| DE2617440A1 (de) | 1976-11-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Adams et al. | Structure of Cannabinol. III. Synthesis of Cannabinol, 1-Hydroxy-3-n-amyl-6, 6, 9-trimethyl-6-dibenzopyran1 | |
| US3301857A (en) | Spiro | |
| SU509220A3 (ru) | Способ получени производныхкарбазола или их опти-ческих изомеров,или их солей | |
| US3403157A (en) | Benzo[6, 7]cyclohepta[1, 2, 3-d, e]isoquinoline derivatives | |
| SU460626A3 (ru) | Способ получени винкамина или его производных | |
| US2712031A (en) | Monosubstituted salicylaldehyde alkoximes | |
| Bradsher et al. | Aromatic Cyclodehydration. XXXVI. 1, 2 The Synthesis of (±)-Cryptopleurine | |
| SU635872A3 (ru) | Способполучени производных 2-оксиимино-1,2,3,4,6,7-гексагидро-11 в н-бензо/а/-хинолизина или их солей | |
| SU421187A3 (ru) | Способ получения 2-(фурилметил)-6,7- бензоморфанов | |
| US3215705A (en) | 4-amino-3-hydroxymethyl indole derivatives | |
| US2175843A (en) | Polyene carboxylic acids and esters and manufacture thereof | |
| US3954767A (en) | Piperazine salts of 2,5-dihydroxy benzene sulfonic acid mono- and diesters | |
| NO771771L (no) | Fremgangsm}te for fremstilling av nye derivater av dibenzo(de, h)kinolin | |
| US3052678A (en) | Basic ethers of n-heterocyclic | |
| SU895288A3 (ru) | Способ получени 5-замещенных 10,11,-дигидро-5н-дибензо( @ , @ ) циклогептен-5,10-иминов | |
| US2508937A (en) | 4-methyl-8-(dialkyl aminoalkylamino) quinolines and method for their production | |
| US3227719A (en) | Pyrazines | |
| US3058992A (en) | Intermediates for the preparation of | |
| SU422149A3 (ru) | Способ получения производных азепина или их солеи | |
| US2974143A (en) | Dibenzo [de, g] quinoline compounds | |
| SU584782A3 (ru) | Способ получени производных аминоимидазоизохинолина или их солей | |
| US3303195A (en) | Methylated deserpidine | |
| SU514829A1 (ru) | Способ получени 5-замещенных 5н-дибензо ( , )-азепинов | |
| US2221828A (en) | Esters of amino alcohols with 9-hydroxyfluorene-9-carboxylic acid and processes for their production | |
| US3301858A (en) | Or< vii |